Concepedia

Sergio Rodríguez‐Arévalo

SR

Statistics

Publications

10

Citations

224

H-Index

10

Active since

2016

Affiliations

Universitat de Barcelona(Current)

Universitat de les Illes Balears

University of the Basque Country

Research Institute of Health Sciences

Universitat Autònoma de Barcelona

Sergio Rodríguez‐Arévalo is an author at Universitat de Barcelona specializing in pharmacology, neuropharmacology, and medicine.

ORCID

Publications per year

2016–2021

10

Publications

10

Phosphoenolpyruvate from Glycolysis and PEPCK Regulate Cancer Cell Fate by Altering Cytosolic Ca2+

Juan Moreno-Felici, Petra Hyroššová, Marc Aragó et al. · Cells · 2019 · 37 citations · Full text

, , +17

Neuroprotective Effects of a Structurally New Family of High Affinity Imidazoline I<sub>2</sub>Receptor Ligands

Sònia Abás, Amaia M. Erdozain, Benjamin Keller et al. · ACS Chemical Neuroscience · 2016 · 31 citations

, , +17

Disease‐modifying treatment with I<sub>2</sub> imidazoline receptor ligand LSL60101 in an Alzheimer's disease mouse model: a comparative study with donepezil

Foteini Vasilopoulou, Sergio Rodríguez‐Arévalo, Andrea Bagán et al. · British Journal of Pharmacology · 2021 · 27 citations · Full text

, , +17

Behavioral and Cognitive Improvement Induced by Novel Imidazoline I2 Receptor Ligands in Female SAMP8 Mice

Christian Griñán‐Ferré, Foteini Vasilopoulou, Sònia Abás et al. · Neurotherapeutics · 2018 · 25 citations · Full text

, , +12

Bicyclic α-Iminophosphonates as High Affinity Imidazoline I<sub>2</sub> Receptor Ligands for Alzheimer’s Disease

Sònia Abás, Sergio Rodríguez‐Arévalo, Andrea Bagán et al. · Journal of Medicinal Chemistry · 2020 · 23 citations · Full text

, , +17

1–5 of 10